Offerings
Products
Distribution Products
- Mutual Funds
- Basket Investing
Services
- Demat Account
- 3 in 1 Account
Tools & Platforms
Platform
Tools & Calculators
- Open API
- Calculators
Markets
Stocks
F&O
Mutual Funds
ETFs
More
Research
Pricing
Resources

Sector: Pharmaceuticals & Biotechnology

Small Cap

Ind-Swift Laboratories Share Price

Q: What is the current share price of Ind-Swift Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ind-Swift Laboratories Ltd. is ₹ 143.48 on the NSE and ₹ 144.1 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

Q: What is the Market Capitalization of Ind-Swift Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ind-Swift Laboratories Ltd. is approximately ₹ 1243.8 Cr.

Q: What are the PE and PB ratios for Ind-Swift Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ind-Swift Laboratories Ltd. is 5, and the Price-to-Book (PB) ratio is 0.9.

Q: What is the 52-Week High and Low for Ind-Swift Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ind-Swift Laboratories Ltd. shares was ₹ 156.8, and the lowest price was ₹ 68.72.

Q: Who are the major shareholders of Ind-Swift Laboratories Ltd.?

Significant shareholdings in Ind-Swift Laboratories Ltd. typically include entities such as: Promoter Public FII Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Ind-Swift Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ind-Swift Laboratories Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

Q: What is the latest dividend information for Ind-Swift Laboratories Ltd.?

Ind-Swift Laboratories Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2011. The record date was set as 2011-09-20, and the payment was/is scheduled around 2011-09-20. For the most current dividend announcements, refer to official company filings.

Ind-Swift Laboratories Ltd.

₹143.48

-6.80(-4.52%)

Trade Now

9th Apr 2026 | 3:28 PM

NSE : INDSWFTLAB

Open Free Demat Account

Ind-Swift Laboratories Performance

Price Movement

₹143.48

₹142.00

₹156.80

↘ Today's Low↗ Today's High

1 Year Performance

₹143.48

₹68.72

₹154.65

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹156.80

Low₹142.00

Open at₹151.46

Prev Close₹150.28

Volumes24.52 L

Avg Price₹147.40

Lower Circuit₹120.23

Upper Circuit₹180.33

Historical Performance

3M High₹156.80

3M Low₹89.00

1 Yr High₹156.80

1 Yr Low₹68.72

3 Yr High₹186.00

3 Yr Low₹61.45

5 Yr High₹186.00

5 Yr Low₹52.65

Ind-Swift Laboratories Fundamentals

Market Cap

Above industry Median

1,243.80 Cr.

PE Ratio (TTM)

Low in industry

Dividend Yield

Net Profit TTM

3.5% incr over last year

248.57

Net Profit Growth

3.5% incr over last year

248.57

PEG Ratio

High in industry

1.40

ROE

53% decr over last year

21.32

Operating Revenue TTM

594.47

Operating Revenue Growth

33.0% incr over last year

Book Value

Low in industry

0.90

MFI

MFI is mid-range

61.44

RSI

RSI is mid-range

60.33

EPS (TTM)

37.25

Debt to Equity

0.02

Face Value

Operating Profit Margin Qtr.

-3.02

Operating Profit Qtr.

4.18

Net Profit Qtr.

9.54

Operating Revenue Qtr.

150.85

PB Ratio

0.90

Ind-Swift Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	149.48	150.44	147.99	144.75	1.41
Operating Expense	144.08	148.25	144.92	158.21	10.22
Operating Profit	5.40	2.19	3.07	-13.47	-8.81
Depreciation	8.84	6.98	6.68	7.44	0.25
Interest	0.67	2.01	1.15	-26.76	0.11
Tax	6.87	2.30	1.71	8.06	0
Net Profit	10.74	8.76	8.12	218.09	4.64

Ind-Swift Laboratories Technicals

Ind-Swift Laboratories Ltd. EMA & SMA

₹143.48

-6.80 (-4.52%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹142.4

Day EMA10 ₹140.7

Day EMA12 ₹140.5

Day EMA20 ₹139.6

Day EMA26 ₹138.6

Day EMA50 ₹132.5

Day EMA100 ₹122.4

Day EMA200 ₹113.7

Ind-Swift Laboratories Support and Resistance

Resistance

First Resistance₹157.29

Second Resistance₹164.29

Third Resistance₹173.94

Support

First Support₹140.64

Second Support₹130.99

Third Support₹123.99

Technical Indicators

Day RSI60.33

Day MFI61.44

Day ADX15.52

Day Commodity Channel Index153.90

William-18.10

Day MACD1.88

Day MACD Signal Line1.85

Day ATR8.90

Day ROC12554.55

Day ROC219.49

Ind-Swift Laboratories Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	42	42	40.9	40.9	39.5	39.5
FII	0.6	0.5	3.1	4.3	14.8	14.3
DII	1	0.9	0.9	0.9	0.7	0.7
Public	56.4	56.6	55.1	53.9	45	45.5

Ind-Swift Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	21.09 L	42.12 L	50.08%
Week	6.03 L	12.22 L	49.37%
1 Month	3.01 L	6.36 L	47.31%
6 Month	1.86 L	4.55 L	40.85%

Ind-Swift Laboratories SWOT Analysis

Strengths29

Weakness6

Opportunity0

Threats0

MACD Crossover Above Signal Line

Price crossing above SMA20 today, and greater than SMA5

Strong Performer, Getting Expensive (DVM)

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Relative Outperformance versus Industry over 1 Month

Affordable Stocks with High ROE and Momentum

Stringent DVM Screener

Weekly Screener: High Momentum Score Stocks (subscription)

PEG lower than Industry PEG

Stocks gaining versus previous close, open price and RSI

New 52 week high today

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Relative Outperformance versus Industry over 1 Month

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

RSI indicating price strength

MACD crossed above signal line previous end of day

Biggest Price Gainers from Open

New 52 Week High

Volume Shockers

Stocks near 52 Week High with Significant Volumes

Stocks Outperforming their Industry Price Change in the Quarter

Ind-Swift Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Instrument Type
20 Sep, 2011	1	FINAL	Equity Share
16 Sep, 2010	1	FINAL	Equity Share
17 Sep, 2009	1	FINAL	Equity Share
18 Sep, 2008	1	FINAL	Equity Share
21 Sep, 2007	1	FINAL	Equity Share
22 Sep, 2006	1.5	FINAL	Equity Share
22 Sep, 2005	1.5	FINAL	Equity Share
23 Sep, 2004	1	FINAL	Equity Share

Ind-Swift Laboratories Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Amrutanjan Health Care Ltd.	Senores Pharmaceuticals Ltd.
Price (₹)	₹425	₹7.01	₹105.93	₹122.50	₹530.80	₹803.40
% Change	0.77%	4.94%	-3.20%	2.60%	-0.52%	2.57%
Revenue TTM (₹ Cr)	-	₹83.60	₹282.74	-	₹488.20	₹588.52
Net Profit TTM (₹ Cr)	-	₹-34.95	₹15.30	-	₹56.90	₹101.60
PE TTM	-	-1.70	26.90	-	27.00	36.50
1 Year Return	7.83	601	-15.85	33.64	-15.37	54
ROCE	28.91	-5.63	-	-	23.87	9.34

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 679.95

-0.47%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 57.50

-4.01%

SIGACHI

Sigachi Industries Ltd.

₹ 20.70

-1.29%

WINDLAS

Windlas Biotech Ltd.

₹ 798.00

+1.30%

VINEETLAB

Vineet Laboratories Ltd.

₹ 33.15

+2.66%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 480.10

-0.64%

ZIMLAB

Zim Laboratories Ltd.

₹ 70.11

-1.23%

MEDICO

Medico Remedies Ltd.

₹ 38.48

-1.64%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 158.00

-2.48%

LASA

Lasa Supergenerics Ltd.

₹ 7.51

+4.16%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 290.20

-0.90%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 324.90

-0.23%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.80

-4.33%

BROOKS

Brooks Laboratories Ltd.

₹ 71.93

+0.28%

RPGLIFE

RPG Life Sciences Ltd.

₹ 1890.00

+0.93%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 136.13

+10.00%

ALPA

Alpa Laboratories Ltd.

₹ 70.00

-0.34%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 145.72

+7.02%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 415.00

+3.96%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.74

-0.46%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 32.49

+2.91%

INDOCO

Indoco Remedies Ltd.

₹ 202.75

+2.29%

LINCOLN

Lincoln Pharmaceuticals Ltd.

₹ 546.00

-1.14%

FAQ's on INDSWFTLAB

What is the current share price of Ind-Swift Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Ind-Swift Laboratories Ltd. is ₹ 143.48 on the NSE and ₹ 144.1 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Ind-Swift Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Ind-Swift Laboratories Ltd. is approximately ₹ 1243.8 Cr.

What are the PE and PB ratios for Ind-Swift Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Ind-Swift Laboratories Ltd. is 5, and the Price-to-Book (PB) ratio is 0.9.

What is the 52-Week High and Low for Ind-Swift Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Ind-Swift Laboratories Ltd. shares was ₹ 156.8, and the lowest price was ₹ 68.72.

Who are the major shareholders of Ind-Swift Laboratories Ltd.?

Significant shareholdings in Ind-Swift Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Ind-Swift Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Ind-Swift Laboratories Ltd. is often compared with other major players such as Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs and Corona Remedies for analysis and benchmarking.

What is the latest dividend information for Ind-Swift Laboratories Ltd.?

Ind-Swift Laboratories Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2011. The record date was set as 2011-09-20, and the payment was/is scheduled around 2011-09-20. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy